Internal Medicine, Endocrinology, Diabetes, & Metabolism · West Nyack, NY
NPI
1316911654
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2 Crosfield Ave, Ste 204
West Nyack, NY, 10994
Phone (845) 358-6266
Groups this clinician bills Medicare through
Medicare paid, 2024
$526K
25,957 services
Medicare patients, 2024
806
Average age 76
Drug cost, 2024
$3.0M
6,161 prescriptions
Company payments, 2025
$4,030
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan Dresner was code J0897 (injection, denosumab, 1 mg), 4,200 times for 43 patients. In total Alan Dresner billed 25,957 services in 64 codes, and Medicare paid $526K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,200 | 43 | $20.43 | $86K |
| 36415 Venipuncture Blood Collection | Office | 1,549 | 701 | $8.65 | $13K |
| 83036 Blood Count | Office | 1,143 | 525 | $9.52 | $11K |
| 80061 Clinical Chemistry | Office | 1,120 | 638 | $13.12 | $15K |
| 99214 Office E&M - Established | Office | 1,107 | 453 | $111.68 | $124K |
| 84443 Clinical Chemistry | Office | 1,099 | 647 | $16.46 | $18K |
| 84436 Clinical Chemistry | Office | 1,075 | 638 | $6.73 | $7,235 |
| 84480 Clinical Chemistry | Office | 1,075 | 641 | $13.90 | $15K |
| 80048 Clinical Chemistry | Office | 1,074 | 627 | $8.29 | $8,903 |
| 80076 Clinical Chemistry | Office | 1,059 | 620 | $8.01 | $8,483 |
| 84479 Clinical Chemistry | Office | 1,055 | 634 | $6.34 | $6,689 |
| 83735 Clinical Chemistry | Office | 812 | 562 | $6.57 | $5,335 |
| 99213 Office E&M - Established | Office | 686 | 440 | $76.11 | $52K |
| 85025 Blood Count | Office | 652 | 492 | $7.61 | $4,962 |
| 82607 Clinical Chemistry | Office | 614 | 540 | $14.78 | $9,075 |
By year: 2022 $532K for 28,348 services; 2023 $507K for 26,405 services; 2024 $526K for 25,957 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,549 | 701 | $8.65 | $13K |
| 83036 Blood Count | 1,143 | 525 | $9.52 | $11K |
| 80061 Clinical Chemistry | 1,120 | 638 | $13.12 | $15K |
| 84443 Clinical Chemistry | 1,099 | 647 | $16.46 | $18K |
| 84480 Clinical Chemistry | 1,075 | 641 | $13.90 | $15K |
| 84436 Clinical Chemistry | 1,075 | 638 | $6.73 | $7,235 |
| 80048 Clinical Chemistry | 1,074 | 627 | $8.29 | $8,903 |
| 80076 Clinical Chemistry | 1,059 | 620 | $8.01 | $8,483 |
| 84479 Clinical Chemistry | 1,055 | 634 | $6.34 | $6,689 |
| 83735 Clinical Chemistry | 812 | 562 | $6.57 | $5,335 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan Dresner prescribed most often to Medicare patients was Levothyroxine Sodium, with 861 prescriptions and refills. In total Alan Dresner wrote 6,161 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 861 | 2,407 | 220 | $18K |
| Synthroid Levothyroxine Sodium | 465 | 1,325 | 119 | $36K |
| Metformin Hcl Generic | 324 | 801 | 81 | $2,558 |
| Ozempic Semaglutide | 267 | 475 | 59 | $452K |
| Metformin Hcl Er Metformin Hcl | 213 | 557 | 64 | $3,638 |
| Atorvastatin Calcium Generic | 196 | 563 | 60 | $1,626 |
| Farxiga Dapagliflozin Propanediol | 184 | 428 | 49 | $237K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 179 | 473 | 68 | $16K |
| Mounjaro Tirzepatide | 151 | 222 | 32 | $230K |
| Jardiance Empagliflozin | 141 | 247 | 29 | $143K |
| Risedronate Sodium Dr Risedronate Sodium | 140 | 389 | 44 | $37K |
| Glimepiride Generic | 135 | 380 | 39 | $1,457 |
| Nateglinide Generic | 120 | 292 | 33 | $9,215 |
| Rosuvastatin Calcium Generic | 115 | 343 | 35 | $1,419 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 108 | 259 | 35 | $109K |
Brand drugs: 2,934 claims; generic drugs: 2,875 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan Dresner $4,030 ($4,030 in general payments such as food, travel and fees) from 25 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $474.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 21 | $474 |
| Beta Bionics, Inc. BBNX | 15 | $383 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $335 |
| Corcept Therapeutics CORT | 19 | $317 |
| Lilly USA, LLC LLY | 20 | $296 |
| Novo Nordisk Inc NVO | 15 | $270 |
| Mannkind Corporation MNKD | 27 | $261 |
| Sanofi-Aventis U.S. LLC SNY | 7 | $250 |
| Insulet Corporation PODD | 14 | $246 |
| Amgen Inc. AMGN | 10 | $213 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.